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It is well established that canonical Wnt signaling in bone regulates bone mass. Much less is known about
the role of noncanonical Wnt signaling. Maeda and colleagues now report in Nature Medicine that
Wnt5a-Ror2 crosstalk between bone cells enhances bone resorption, thereby negatively regulating skeletal
homeostasis (Maeda et al., 2012).Osteoblasts and osteocytes regulate
osteoclast differentiation and function
through the secretion of the cytokines
RANK Ligand (RANKL) and osteoprote-
gerin (OPG) (Lacey et al., 1998; Naka-
shima et al., 2011). Both lineages are
regulated by canonical (b-catenin-depen-
dent)Wnt signaling, which promotes bone
formation and represses bone resorption.
This last decade has seen remarkable
advances in our understanding of how
canonical Wnt signaling affects bone
development and bone mass, so much
that activation of this pathway through
antibody inhibition of sclerostin is cur-
rently in advanced human clinical trials
(Monroe et al., 2012; Baron et al., 2006;
van Amerongen and Nusse, 2009; Padhi
et al., 2011). Wnt proteins also signal
independently of b-catenin via the nonca-
nonical pathway including several distinct
signaling cascades. However, very little is
known about how this pathway affects
bone homeostasis. Maeda et al. (2012)
provide new insights into the role of non-
canonical Wnt signaling in the regulation
of bone mass and into the crosstalk
between osteoblasts and osteoclasts
(Figure 1).
Early studies on noncanonical Wnt
signaling have shown that Wnt7b pro-
motes osteoblast differentiation through
the Wnt-Gaq/11-PKCd noncanonical cas-
cade, with genetic disruption of Wnt7b
and PKCd, resulting in impaired bone
formation in both mutant mice (Tu et al.,
2007). Also suggesting a positive role of
noncanonical Wnt signaling on bone
mass, Takada et al. (2007) have shown
that Wnt5a heterozygous mice display
an osteopenic phenotype, with de-
creased trabecular bone mass and in-
creased bone marrow adipogenesis.Both of these effects were shown to be
due to noncanonical Wnt signaling
through CAMKII-TAK1-TAB2-NLK-de-
pendent activation of PPARg transcrip-
tional activity (Takada et al., 2007).
Whether Wnt5a signaling also affected
osteoclastogenesis and which receptor(s)
mediate Wnt5a signals were not ad-
dressed. Taken together, these papers
suggested that activation of noncanonical
Wnt signaling favors bone formation and
should increase bone mass.
To activate noncanonical signaling,
Wnt5a binds to Ror2 and Frizzled re-
ceptors, inducing JNK phosphorylation.
Maeda et al. (2012) now show that
Wnt5a/Ror2/JNK crosstalk signaling
between osteoblasts and osteoclast pre-
cursors enhances osteoclast differentia-
tion andbone resorption inmice (Figure 1).
Comparing the expression profile of Wnt
ligands in osteoblasts and bone marrow
macrophages (BMMs), Maeda et al.
(2012) found that while osteoblast-lineage
cells express high levels of Wnt5a and
Ror2, osteoclast precursors express
Ror2 but notWnt5a. Surprisingly, haploin-
sufficiency of Wnt5a or Ror2 resulted in
opposite changes in bone mass. Wnt5a
heterozygosis led to a decrease in both
bone formation and resorption, causing
osteopenia, whereas deletion of one
allele of Ror2 increased bone volume
through reduction of bone resorption
only. Importantly, osteoclastogenesis
was significantly impaired in both mutant
mice, suggesting that whereas Wnt5a
might have Ror2-independent functions
in bone formation, Wnt5a-Ror2 signaling
affects bone mass by regulating osteo-
clastogenesis. The authors reported that
Wnt5a significantly enhances RANKL-
dependent osteoclast differentiation andCell Metabolismthat this effect was abolished in absence
of Ror2. Classical coculture experiments
showed that Wnt5a secreted by osteo-
blast cells, but not Ror2, is required for
differentiation of wild-type osteoclast
precursors.
Maeda and colleagues then used
several genetic tools to further test their
hypothesis. They generated a mouse
expressing Cre recombinase under the
control of the Tnfrsf11a (RANK) promoter
to specifically delete Ror2 in osteoclast
precursors—and used the Osx-Cre mice
to delete Wnt5a in cells of the osteoblast
lineage. The phenotypes of both of
these conditional KO mice mimicked the
phenotypes observed upon global dele-
tion, confirming that Wnt5a secreted by
cells of the osteoblast lineage regulates
osteoclastogenesis through Ror2 sig-
naling in osteoclasts precursors. Using
the cathepsin K-Cre driver to conditionally
delete Ror2 in more mature osteoclasts,
the authors showed that Ror2-mediated
signaling is also required for osteoclast
function (Maeda et al., 2012). Thus, Ror2
signaling is involved in both osteoclast
precursor differentiation and in the regu-
lation of the bone-resorbing activity of
individual mature osteoclasts.
The mechanism by which Wnt5a/Ror2/
JNK signaling enhances RANKL-induced
osteoclastogenesis appears to involve a
strong induction of RANK expression in
osteoclast precursors. Analysis of the
Tnfrsf11a promoter identified a cluster of
Sp1 sites required for Wnt5a-induced
transactivation. Although interactions
between Sp1 sites and c-Jun, a com-
ponent of the AP-1 transcription factor,
have been identified and thought to regu-
late the expression of genes involved in a
variety of cellular functions, this has not15, April 4, 2012 ª2012 Elsevier Inc. 415
Figure 1. Regulation of Osteoblast and Osteoclast Lineages by Canonical and Noncanonical Wnt signaling
Canonical Wnt ligands such as Wnt3a bind to the coreceptor complex of LRP5/6 and Frizzled on cells of the osteoblast lineage (OBL) to stabilize b-catenin,
which translocates to the nucleus and activate target genes, favoring bone formation. Activation of this pathway also represses bone resorption by inducing
secretion of osteoprotegerin (OPG), which binds to RANKL and prevents its interaction with its cognate receptor RANK on osteoclast precursors (OCP).
Noncanonical Wnt ligands, such as Wnt5a, bind to a different coreceptor complex comprising Ror2 (or Ryk) and Frizzled. Activation of this pathway favors
bone formation by inducing Runx2 via JnkNK (Tu et al., 2007) and by repressing PPARg (Takada et al., 2007). Maeda et al. now show that OBL cells also secrete
Wnt5a, which binds to the Ror2-Frizzled receptor complex on OCPs, inducing c-Jun transcription. c-Jun then binds to Sp1 sites on the RANK promoter,
activating its transcription and increasing RANK expression. This in turns increases the sensitivity of OCPs to RANKL, favoring osteoclastogenesis and
bone resorption. The same occurs in mature osteoclasts (OC) to enhance their activity. Thus, the Wnt5a-Ror2 crosstalk between OBLs and OCPs adds
a new mechanism by which OBLs control bone resorption.
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Through an elegant set of experiments,
Maeda and colleagues demonstrate
first that Wnt5a induces c-Jun ex-
pression in osteoclast precursors and
then that Wnt5a transactivates the
Tnfrsf11a promoter by recruiting c-Jun
to the Sp1 sites.
Lastly, in what could be an important
novel therapeutic insight, Maeda et al.
then demonstrate that this b-catenin-
independent Wnt5a-Ror2-JNK signaling
cascade is involved in rheumatoid
arthritis (RA), a disease characterized by
local joint inflammation and devastatingly
increased bone resorption. Along with
several other Wnts, Wnt5a is highly ex-
pressed in the articular synovial tissues
in a mouse model of collagen-induced
arthritis (CIA). Maeda et al. then success-
fully inhibited the destructive bone
erosion, although not reducing the inflam-
matory response, by treating the CIA416 Cell Metabolism 15, April 4, 2012 ª2012mice with a GST-sRor2 fusion protein
that specifically binds to and inhibits
Wnt5a.
Following this elegant study, a number
of questions will now need to be ad-
dressed. It will be important to determine
which specific cells (mesenchymal stem
cells, osteoblasts, precursors, osteoblasts,
or osteocytes) are the main source(s) of
Wnt5a in bone and how Wnt5a expres-
sion/secretion is regulated. Since cells of
the osteoblast lineage express Ror2 and
Frizzled receptors, Wnt5a must activate
an autocrine loop: How does this affect
bone formation? Could this explain the
different phenotypes of Wnt5a and Ror2
heterozygote mice? Is there a Ror2-inde-
pendent effect of Wnt5a? Is Wnt5a acting
through other ‘‘noncanonical’’ receptors
such as Ryk? Finally, it will be of interest
to determine whether we can manipulate
this pathway for the treatment of
osteoporosis.Elsevier Inc.These exciting findings from Maeda
et al. firmly integrate noncanonical Wnt
signaling in the direct control of bone
resorption in both physiological and
disease conditions, potentially opening
new therapeutic avenues for the treat-
ment of RA, osteoporosis and other
bone diseases characterized by en-
hanced bone resorption. These observa-
tions also broaden our knowledge of the
role of Wnt proteins in activating different
signaling pathways to ultimately elicit
specific cellular responses in the context
of bone homeostasis.REFERENCES
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In this issue ofCell Metabolism, Ristow and colleagues (Zarse et al., 2012) elucidate a conserved mechanism
through which reduced insulin-IGF1 signaling activates an AMP-kinase-driven metabolic shift toward oxida-
tive proline metabolism. This, in turn, produces an adaptive mitochondrial ROS signal that extends worm life
span. These findings further bolster the concept of mitohormesis as a critical component of conserved aging
and longevity pathways.Historically, reactive oxygen species
(ROS) produced bymitochondrial respira-
tion have been associated with cellular
damage that accelerates aging and
limits life span (Balaban et al., 2005). By
extension, increased stress resistance or
endogenous ROS detoxification systems
are key outcomes of many life span-
extending interventions (Kourtis and
Tavernarakis, 2011). Studies over the
last decade, however, have challenged
the concept of ROS as simply detrimental,
proaging molecules. Under certain condi-
tions, such as during the active phases of
yeast growth or worm (C. elegans) devel-
opment, elevated ROS function as sig-
naling molecules that increase stress
resistance and delay aging at later devel-
opmental stages (Pan et al., 2011; Yang
and Hekimi, 2010). This adaptive re-
sponse to ROS, often called mitochon-
drial hormesis or mitohormesis, has
emerged as a new and important com-
ponent of conserved aging and longevity
pathways (Ristow and Schmeisser,
2011). Indeed, many interventions that
extend life span in model organisms,
such as reduced signaling through the
target of rapamycin (TOR) pathway,
caloric restriction (CR), and exercise, relyat least partially on mitohormesis (Pan
et al., 2011; Schulz et al., 2007; Yang
and Hekimi, 2010). We may now also
add insulin/IGF1 signaling (IIS) to this list,
as work by Zarse et al. in this issue iden-
tifies a key role for AMPK-regulated
oxidative proline catabolism in initiating
adaptive mitochondrial ROS signaling,
which extends life span under conditions
of reduced IIS (Zarse et al., 2012).
In model organisms, reduced IIS
extends life span in part via increasing
stress resistance and altering metabolism
(Baumeister et al., 2006). Using both
worm and mouse cell culture models,
Zarse et al. (2012) confirmed that consti-
tutively impaired IIS increases mitochon-
drial respiration but decreases ROS
levels. This seemingly paradoxical finding
could be explained if reducing IIS also
induces ROS detoxification pathways.
Accordingly, RNAi against the insulin-like
receptor DAF-2 in C. elegans revealed
that ROS production increases during
the acute response to reduced IIS, and
elevated antioxidant defenses (e.g., SOD
and catalase) account for the decrease
in total ROS levels observed later. Entirely
consistent with increased ROS func-
tioning as signaling molecules to initiatea mitohormetic response, treatment with
antioxidants during early time points
diminishes the ability of reduced IIS to
extend nematode life span. Furthermore,
the adaptive ROS signal acts through
the worm homologs of p38 (PMK-1) and
NRF-2 (SKN-1) to ultimately induce SOD
and catalase gene expression, promoting
stress resistance during aging.
Insulin signaling tightly regulates glu-
cose metabolism to maintain cell function
in the presence of fluctuating nutrient
availability. To address the mechanism
by which reduced IIS induces ROS
production, Zarse and colleagues (Zarse
et al., 2012) used RNA-seq in worm and
mouse models of reduced IIS. This
approach revealed a shift in metabolism
that includes AMPK-dependent induction
of genes required for mitochondrial pro-
line catabolism. Supporting the impor-
tance of proline in life span extension,
RNAi knockdown of the implicated pro-
line oxidase/dehydrogenase abrogates
some of the life span-extending effects
of reduced IIS. Furthermore, proline sup-
plementation alone extended worm life
span. This led Zarse et al. to conclude that
proline catabolism provides substrates to
support mitochondrial respiration (i.e.,15, April 4, 2012 ª2012 Elsevier Inc. 417
